Updates are available Correction dated 2024-01-12
Click to view Correction: https://doi.org/10.1186/s13195-023-01374-8
-
Authors
Xie, Long
Das, Sandhitsu R.
Wisse, Laura E. M.
Ittyerah, Ranjit
de Flores, Robin
Shaw, Leslie M.
Yushkevich, Paul A.
Wolk, David A.
,
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01-AG056014, R01-AG040271, P30-AG010124, R01-EB017255, R01-AG055005, R01-AG070592, R01-AG056014, R01-AG040271, P30-AG010124, R01-EB017255, R01-AG055005, R01-AG070592, R01-AG056014, R01-AG040271, P30-AG010124, R01-EB017255, R01-AG055005, R01-AG070592, R01-AG056014, R01-AG040271, P30-AG010124, R01-EB017255, R01-AG055005, R01-AG070592, R01-AG056014, R01-AG040271, P30-AG010124, R01-EB017255, R01-AG055005, R01-AG070592, R01-AG056014, R01-AG040271, P30-AG010124, R01-EB017255, R01-AG055005, R01-AG070592)
MultiPark - A strategic Research Area at Lund University
Fondation Philippe Chatrier
- License Information
-
More Information
Article History
Received: 22 August 2022
Accepted: 13 March 2023
First Online: 11 April 2023
Change Date: 12 January 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13195-023-01374-8
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki. All research activities were approved by Institutional Review Boards (IRB) at the participating study sites. Participants provided written informed consent.
: Not applicable
: Dr. Wolk received grants from Eli Lilly/Avid Radiopharmaceuticals, grants from Merck, grants from Biogen, personal fees from Janssen, and personal fees from GE Healthcare and serves on a DSMB for Functional Neuromodulation.Dr. Xie received personal consulting fees from Galileo CDS, Inc. Dr. Xie has become an employee of Siemens Healthineers since May 2022, but the current study was conducted during his employment at the University of Pennsylvania.Dr. Das received personal fees from Rancho Biosciences.
